Does neither short-term nor long-term administration of oral choline alter metabolite concentrations in human brain?
Previous reports of increased Cho are not confirmed.
In conclusion, intratracheal DeltaN23-KGF treatment is not effective to prevent acute pulmonary allograft rejection.